ALFA Finder
15:34 IST
BSE
Board Meeting Date
Jenburkt Pharmaceuticals Board Meeting Date
Jenburkt Pharmaceuticals has intimated that its Board will meet on 3 Nov 2026 to consider Q2/H1-26 financial results. No decision has been taken yet.
Jenburkt Pharmaceuticals Ltd
- Share price
- ₹963.45
- Market cap
- ₹425.2 Cr
- Revenue (annual)
- ₹168.7 Cr
- Net profit (annual)
- ₹34.74 Cr
- P/E (TTM)
- 12.9×Sector 43.8×
- Promoter holding
- 46.62%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Other Announcement 5Financial Results 5Board Meeting Date 3Management Change 2Capital Structure Change 2Annual General Meeting 2Dividend 1Debt & Borrowing 1
Time
3 announcements with these filters
17:29 IST
BSE
Board Meeting Date
Jenburkt Pharmaceuticals Board Meeting Date
Jenburkt Pharmaceuticals scheduled a board meeting for August 6, 2026, to consider the company's standalone unaudited financial results for the quarter ended June 30, 2026.
16:44 IST
BSE
Board Meeting Date
Jenburkt Pharmaceuticals Board Meeting Date
Jenburkt Pharmaceuticals Ltd has scheduled a board meeting on May 05, 2026. The board will review audited financial results for the quarter and year ended March 31, 2026, and consider a dividend recommendation.